These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23090607)

  • 1. Regulation of JAK/STAT signalling by SOCS in the myocardium.
    Shi J; Wei L
    Cardiovasc Res; 2012 Dec; 96(3):345-7. PubMed ID: 23090607
    [No Abstract]   [Full Text] [Related]  

  • 2. SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway.
    Cittadini A; Monti MG; Iaccarino G; Castiello MC; Baldi A; Bossone E; Longobardi S; Marra AM; Petrillo V; Saldamarco L; During MJ; Saccà L; Condorelli G
    Cardiovasc Res; 2012 Dec; 96(3):381-90. PubMed ID: 22875468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
    Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
    Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
    Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
    Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway.
    Diao Y; Wang X; Wu Z
    Mol Cell Biol; 2009 Sep; 29(18):5084-93. PubMed ID: 19620279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
    Zhang WN; Wang L; Wang Q; Luo X; Fang DF; Chen Y; Pan X; Man JH; Xia Q; Jin BF; Li WH; Li T; Liang B; Chen L; Gong WL; Yu M; Li AL; Zhou T; Li HY
    J Biol Chem; 2012 Jan; 287(1):382-392. PubMed ID: 22084247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling.
    Kurdi M; Booz GW
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):126-41. PubMed ID: 17703129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
    Qiu X; Guo G; Chen K; Kashiwada M; Druker BJ; Rothman PB; Chen JL
    Neoplasia; 2012 Jun; 14(6):547-58. PubMed ID: 22787435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
    Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
    Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
    Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
    Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells.
    Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS
    Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the JAK/STAT3/SOCS3 signaling pathway in herniated lumbar discs.
    Osuka K; Usuda N; Aoyama M; Yamahata H; Takeuchi M; Yasuda M; Takayasu M
    Neurosci Lett; 2014 May; 569():55-8. PubMed ID: 24686183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of a JAK/STAT pathway inhibitor: cytokine inducible SH2 containing protein in breast cancer.
    Borgés S; Moudilou E; Vouyovitch C; Chiesa J; Lobie P; Mertani H; Raccurt M
    Adv Exp Med Biol; 2008; 617():321-9. PubMed ID: 18497055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
    Fischer P; Hilfiker-Kleiner D
    Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel viral SOCS from infectious spleen and kidney necrosis virus: interacts with Jak1 and inhibits IFN-α induced Stat1/3 activation.
    Guo CJ; Yang LS; Zhang YF; Wu YY; Weng SP; Yu XQ; He JG
    PLoS One; 2012; 7(7):e41092. PubMed ID: 22844427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.